CLINICAL-STUDIES OF DESTRUCTIVE SPONDYLOARTHROPATHY IN LONG-TERM HEMODIALYSIS-PATIENTS

被引:57
作者
MARUYAMA, H
GEJYO, F
ARAKAWA, M
机构
[1] Department of Medicine (II), Niigata Univ. School of Medici, Niigata 951, 1-757, Asahimachi-Dori
来源
NEPHRON | 1992年 / 61卷 / 01期
关键词
DESTRUCTIVE SPONDYLOARTHROPATHY; VERTEBRAL RIM EROSION; DIALYSIS AMYLOIDOSIS; MAGNETIC RESONANCE IMAGING;
D O I
10.1159/000186832
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Destructive spondyloarthropathy (DSA) has recently been recognized in hemodialysis patients. This study was undertaken to assess the prevalence, preferred sites, risk factors, early radiological manifestations, magnetic resonance imaging (MRI) and relation to other radiological features and biochemical variables in DSA. In 405 patients undergoing dialysis for 0.2-20.5 years (average 8.2) with a mean age of 51.9 years (range 24-84), a diagnosis of DSA was made for 37 (9.1%). The preferred site of DSA was the lower cervical spine. MRI indicated a low signal intensity of the involved vertebral regions on both T1- and T2-weighted images and thus appeared useful in the exclusion of osteomyelitis showing high-intensity T2-weighted images. The patients were divided into three groups according to radiological findings: those showing (A) the presence of DSA, (B) vertebral rim erosion (VRE) without DSA, and (C) the absence of DSA and VRE. Patient age at onset of dialysis (p < 0.01) and duration of hemodialysis (p < 0.05) appeared to be the associated risk factors for DSA. DSA was found correlated with carpal tunnel syndrome (p < 0.01), carpal bone cystic radiolucency (p < 0.01), and amyloid deposit (p < 0.01). All the groups were essentially the same with respect to the incidence of ectopic calcification, secondary hyperparathyroidism, biochemical markers and sex distribution. The results of this study show DSA to be associated with dialysis amyloidosis.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 34 条
[1]   HEMODIALYSIS IS NOT ESSENTIAL FOR THE DEVELOPMENT OF DESTRUCTIVE SPONDYLARTHROPATHY IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
ALCALAY, M ;
GOUPY, MC ;
AZAIS, I ;
BONTOUX, D .
ARTHRITIS AND RHEUMATISM, 1987, 30 (10) :1182-1186
[2]  
ALLAIN TJ, 1988, BRIT MED J, V296, P12
[3]   SYNOVIAL AMYLOIDOSIS IN PATIENTS UNDERGOING LONG-TERM HEMODIALYSIS [J].
BARDIN, T ;
KUNTZ, D ;
ZINGRAFF, J ;
VOISIN, MC ;
ZELMAR, A ;
LANSAMAN, J .
ARTHRITIS AND RHEUMATISM, 1985, 28 (09) :1052-1058
[4]   HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS AND BETA-2 MICROGLOBULIN - CLINICAL AND IMMUNOHISTOCHEMICAL STUDY [J].
BARDIN, T ;
ZINGRAFF, J ;
SHIRAHAMA, T ;
NOEL, LH ;
DROZ, D ;
VOISIN, MC ;
DRUEKE, T ;
DRYLL, A ;
SKINNER, M ;
COHEN, AS ;
KUNTZ, D .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (03) :419-424
[5]   EARLY AND LATE OCCURRENCES OF DESTRUCTIVE SPONDYLOARTHROPATHY IN HEMODIALYZED PATIENTS [J].
BINDI, P ;
LAVAUD, S ;
BERNIEH, B ;
TOUPANCE, O ;
CHANARD, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (03) :199-203
[6]   CARPAL-TUNNEL SYNDROME AND TYPE OF DIALYSIS MEMBRANE [J].
CHANARD, J ;
BINDI, P ;
LAVAUD, S ;
TOUPANCE, O ;
MAHEUT, H ;
LACOUR, F .
BRITISH MEDICAL JOURNAL, 1989, 298 (6677) :867-868
[7]   EFFECT OF DIALYSIS MEMBRANE AND PATIENTS AGE ON SIGNS OF DIALYSIS-RELATED AMYLOIDOSIS [J].
DESTRIHOU, CV ;
JADOUL, M ;
MALGHEM, J ;
MALDAGUE, B ;
JAMART, J .
KIDNEY INTERNATIONAL, 1991, 39 (05) :1012-1019
[8]   APATITE DEPOSITION DISEASE - NEW ARTHROPATHY [J].
DIEPPE, PA ;
HUSKISSON, EC ;
CROCKER, P ;
WILLOUGHBY, DA .
LANCET, 1976, 1 (7954) :266-269
[9]  
HARDOUIN P, 1987, J RHEUMATOL, V14, P780
[10]   DIALYSIS RELATED ARTHROPATHY - A SURVEY OF 95 PATIENTS RECEIVING CHRONIC-HEMODIALYSIS WITH SPECIAL REFERENCE TO BETA-2 MICROGLOBULIN RELATED AMYLOIDOSIS [J].
HURST, NP ;
VANDENBERG, R ;
DISNEY, A ;
ALCOCK, M ;
ALBERTYN, L ;
GREEN, M ;
PASCOE, V .
ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (05) :409-420